Rocuronium Injection, Solution
Product Images NDC 66794-228

Product Visual Gallery

This gallery contains 8 technical images submitted to the FDA as part of the official labeling for Rocuronium (NDC 66794-228). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Piramal Critical Care Inc, these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

Structure (Rocuronium Structure)

Chemical structure of Rocuronium, showing its steroidal framework with a quaternary ammonium group and ester functional groups. The structure includes a bromide counterion (Br-) and various substituents, illustrating the molecular configuration of this neuromuscular blocking agent.*

FDA Label Image

Ctn-100 (Ctn 100mg)

Rocuronium Bromide Injection 100 mg/10 mL (10 mg/mL) carton for intravenous use only by Piramal Critical Care Inc. The label highlights a warning that it is a paralyzing agent and indicates the package contains 10 multi-dose vials of 10 mL each. Storage and manufacturing details also appear on the label.*

FDA Label Image

Ctn-50 (Ctn 50mg)

Packaging label for Rocuronium Bromide Injection, 50 mg/5 mL (10 mg/mL) solution for intravenous use. The label states 'Rx only' and includes a warning for its paralyzing agent effect. The drug is packaged in 10 x 5 mL multi-dose vials. Manufactured by Piramal Critical Care Inc, the label also contains storage and usage instructions along with a barcode.*

FDA Label Image

Figure1 (Figure1)

A scatter plot with box and whisker summaries depicting time in minutes on the vertical axis, plotted against different mg/kg dosages of Rocuronium for three age groups: 18-64 years, ≥ 65 years, and 1-12 years. The chart compares durations of effect at various dosage levels.*

FDA Label Image

Figure2 (Figure2)

A box plot chart displaying the duration in minutes on the vertical axis, plotted against different Rocuronium dosages in mg/kg and age groups on the horizontal axis, ranging from 18-64 years to 1-12 years. The data illustrate variation in response times by dosage and age group.*

FDA Label Image

Figure3 (Figure3)

A line graph plotting time in minutes on the vertical axis against dose number on the horizontal axis. Two data series represent differing doses labeled 0.1 mg/kg and 0.15 mg/kg, with the higher dose generally corresponding to longer times. Sample sizes for each dose group are indicated as N=29 and N=13, respectively.*

FDA Label Image

Lbl-100 (Lbl 100mg)

Rocuronium Bromide Injection 100 mg/10 mL (10 mg/mL) multi-dose vial label for intravenous use only, manufactured by Piramal Critical Care Inc. Includes warnings about paralytic agent effects, storage instructions under refrigeration, and directions for use. The label features dosage strength, route, and handling precautions.*

FDA Label Image

Lbl-50 (Lbl 50mg)

Label for Rocuronium Bromide Injection 50 mg/5 mL (10 mg/mL) intravenous solution for injection. It is a 5 mL multi-dose vial labeled for prescription use only. The label includes warnings highlighting that it is a paralyzing agent requiring facilities for artificial respiration. Manufactured by Piramal Critical Care Inc.*

* About these descriptions: Image descriptions on this page are generated by automated AI analysis of the product label images from the manufacturer's FDA label submission (SPL). They are provided for reference only and may contain errors or omissions. Always rely on the printed label itself and the official FDA labeling, and consult a pharmacist or healthcare professional with any questions about this product.